vimarsana.com

Page 2 - நிக்கோலஸ் கோப்பர்நிக்கஸ் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Uti Possidetis and Nigerian Fulani Herders Claim of Terra Nullius: The Truth about the Untruths

Uti Possidetis and Nigerian Fulani Herders Claim of Terra Nullius: The Truth about the Untruths
thisdaylive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thisdaylive.com Daily Mail and Mail on Sunday newspapers.

Imagining a post-populist media in Central and Eastern Europe

Imagining a post-populist media in Central and Eastern Europe
emerging-europe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emerging-europe.com Daily Mail and Mail on Sunday newspapers.

Invasive Treatment for Stable CAD: Is There a Cardiac Mortality Benefit?

email article Patients with stable coronary artery disease (CAD) who underwent coronary revascularization had the benefit of decreased cardiac mortality in subsequent years, according to a meta-analysis pooling ISCHEMIA, COURAGE, and other randomized trials. Cardiac mortality risk was reduced in revascularized patients compared with peers assigned to medical therapy alone (RR 0.79, 95% CI 0.67-0.93), reported Eliano Navarese, MD, PhD, of Nicolaus Copernicus University in Toruń, Poland, at the virtual European Association of Percutaneous Cardiovascular Interventions (EuroPCR) meeting. The benefits of revascularization and of optimized medical therapy are additive and the combination is required to achieve maximal and durable prevention of adverse events, Navarese said.

Elective Revascularization, Better Long-term Survival: Meta-analysis

  (UPDATED) Looking once again at a question that many cardiologists considered settled, a new meta-analysis suggests that patients with stable coronary artery disease undergoing elective revascularization are at a lower risk of dying from cardiac causes over the long term when compared with patients treated with medical therapy alone. The findings, presented today as a late-breaking clinical trial at EuroPCR 2021, and simultaneously published in the European Heart Journal, seem to fly in the face of the randomized ISCHEMIA trial findings, published last year. In this analysis, the benefit appeared directly related to the duration of follow-up, with investigators reporting that the longer the follow-up, the lower the risk of cardiac death and spontaneous MI among those who underwent PCI or CABG surgery.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.